These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12886759)

  • 21. Cystic kidney diseases: learning from animal models.
    Fischer E; Gresh L; Reimann A; Pontoglio M
    Nephrol Dial Transplant; 2004 Nov; 19(11):2700-2. PubMed ID: 15496558
    [No Abstract]   [Full Text] [Related]  

  • 22. Genetic interaction studies link autosomal dominant and recessive polycystic kidney disease in a common pathway.
    Garcia-Gonzalez MA; Menezes LF; Piontek KB; Kaimori J; Huso DL; Watnick T; Onuchic LF; Guay-Woodford LM; Germino GG
    Hum Mol Genet; 2007 Aug; 16(16):1940-50. PubMed ID: 17575307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A mouse model for cystic biliary dysgenesis in autosomal recessive polycystic kidney disease (ARPKD).
    Moser M; Matthiesen S; Kirfel J; Schorle H; Bergmann C; Senderek J; Rudnik-Schöneborn S; Zerres K; Buettner R
    Hepatology; 2005 May; 41(5):1113-21. PubMed ID: 15830394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular characterization of Pkd2(+/LacZ) mice, an animal model for the autosomal dominant polycystic kidney disease type 2 (ADPKD2).
    Stypmann J; Engelen MA; Orwat S; Bilbilis K; Rothenburger M; Eckardt L; Haverkamp W; Horst J; Dworniczak B; Pennekamp P
    Int J Cardiol; 2007 Aug; 120(2):158-66. PubMed ID: 17182135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inherited polycystic kidney disease in children.
    McDonald RA; Avner ED
    Semin Nephrol; 1991 Nov; 11(6):632-42. PubMed ID: 1767136
    [No Abstract]   [Full Text] [Related]  

  • 26. A truncated polycystin-2 protein causes polycystic kidney disease and retinal degeneration in transgenic rats.
    Gallagher AR; Hoffmann S; Brown N; Cedzich A; Meruvu S; Podlich D; Feng Y; Könecke V; de Vries U; Hammes HP; Gretz N; Witzgall R
    J Am Soc Nephrol; 2006 Oct; 17(10):2719-30. PubMed ID: 16943309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular and cellular pathophysiology of autosomal recessive polycystic kidney disease (ARPKD).
    Sweeney WE; Avner ED
    Cell Tissue Res; 2006 Dec; 326(3):671-85. PubMed ID: 16767405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Centrosome overduplication and mitotic instability in PKD2 transgenic lines.
    Burtey S; Riera M; Ribe E; Pennenkamp P; Rance R; Luciani J; Dworniczak B; Mattei MG; Fontés M
    Cell Biol Int; 2008 Oct; 32(10):1193-8. PubMed ID: 18725310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Water for ADPKD? Probably, yes.
    Torres VE
    J Am Soc Nephrol; 2006 Aug; 17(8):2089-91. PubMed ID: 16837639
    [No Abstract]   [Full Text] [Related]  

  • 30. Autosomal dominant polycystic kidney disease (ADPKD, MIM 173900, PKD1 and PKD2 genes, protein products known as polycystin-1 and polycystin-2).
    Boucher C; Sandford R
    Eur J Hum Genet; 2004 May; 12(5):347-54. PubMed ID: 14872199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haploinsufficiency of Pkd2 is associated with increased tubular cell proliferation and interstitial fibrosis in two murine Pkd2 models.
    Chang MY; Parker E; Ibrahim S; Shortland JR; Nahas ME; Haylor JL; Ong AC
    Nephrol Dial Transplant; 2006 Aug; 21(8):2078-84. PubMed ID: 16720597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined cystic disease of the liver and kidney.
    D'Agata ID; Jonas MM; Perez-Atayde AR; Guay-Woodford LM
    Semin Liver Dis; 1994 Aug; 14(3):215-28. PubMed ID: 7939783
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical and pathologic findings in two new allelic murine models of polycystic kidney disease.
    Vogler C; Homan S; Pung A; Thorpe C; Barker J; Birkenmeier EH; Upadhya P
    J Am Soc Nephrol; 1999 Dec; 10(12):2534-9. PubMed ID: 10589692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of multiorgan pathology in the wpk rat model of polycystic kidney disease.
    Gattone VH; Tourkow BA; Trambaugh CM; Yu AC; Whelan S; Phillips CL; Harris PC; Peterson RG
    Anat Rec A Discov Mol Cell Evol Biol; 2004 Apr; 277(2):384-95. PubMed ID: 15052665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early manifestations of polycystic kidney disease.
    Bergmann C; Zerres K
    Lancet; 2007 Jun; 369(9580):2157. PubMed ID: 17604790
    [No Abstract]   [Full Text] [Related]  

  • 36. Gene time for polycystic kidney disease.
    Avner ED
    Lancet; 1994 Sep; 344(8926):833-4. PubMed ID: 7916394
    [No Abstract]   [Full Text] [Related]  

  • 37. PKD1 haploinsufficiency causes a syndrome of inappropriate antidiuresis in mice.
    Ahrabi AK; Terryn S; Valenti G; Caron N; Serradeil-Le Gal C; Raufaste D; Nielsen S; Horie S; Verbavatz JM; Devuyst O
    J Am Soc Nephrol; 2007 Jun; 18(6):1740-53. PubMed ID: 17475819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autosomal dominant polycystic kidney disease.
    Gabow PA
    N Engl J Med; 1993 Jul; 329(5):332-42. PubMed ID: 8321262
    [No Abstract]   [Full Text] [Related]  

  • 39. Hypertension and left ventricular hypertrophy in autosomal dominant polycystic kidney disease.
    Ecder T; Schrier RW
    Expert Rev Cardiovasc Ther; 2004 May; 2(3):369-74. PubMed ID: 15151483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induced pluripotent stem cells from polycystic kidney disease patients: a novel tool to model the pathogenesis of cystic kidney disease.
    Hofherr A; Köttgen M
    J Am Soc Nephrol; 2013 Oct; 24(10):1507-9. PubMed ID: 24009236
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.